Biocon's Bengaluru facility issued Form 483 by USFDA; stock down ~1%

At the conclusion of the inspection of the Bengaluru facility, which took place between 20-24, 2020, the agency issued a Form 483, with five observations.

from India Infoline News Service https://ift.tt/38FkbuJ